<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39379877</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-244X</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>BMC psychiatry</Title><ISOAbbreviation>BMC Psychiatry</ISOAbbreviation></Journal><ArticleTitle>A Suicide Attempt Multicomponent Intervention Treatment (SAMIT Program): study protocol for a multicentric randomised controlled trial.</ArticleTitle><Pagination><StartPage>666</StartPage><MedlinePgn>666</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">666</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12888-024-06113-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Suicide has become a first-order public health concern, especially following the negative impact of COVID-19 on the mental health of the general population. Few studies have analysed the effects of early psychotherapeutic interventions on subjects who have attempted suicide, and even fewer have focused on those hospitalized in non-psychiatric units after a Medically Serious Suicide Attempt (MSSA). The main aim of this study is to describe the protocol designed to evaluate the effectiveness of individual psychological treatment for patients hospitalized after an MSSA. The secondary objectives of the study are: (1) to evaluate the impact on quality of life and other psychosocial variables of patients with a recent MSSA who receive early psychological intervention; (2) to analyse the biological, psychological, and clinical impact of early psychotherapeutic treatment on subjects hospitalized after an MSSA.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A longitudinal randomised controlled trial will be conducted with patients over 16 years of age admitted to two general hospitals. The case intervention group will enrol for 8-sessions of individual psychotherapy, Suicide Attempts Multi-component Intervention Treatment (SAMIT), combining Dialectical Behaviour Therapy (DBT), Mentalization-Based Therapy (MBT), and Narrative approaches, while the control group will receive a treatment-as-usual intervention (TAU). Longitudinal assessment will be conducted at baseline (before treatment), post-treatment, and 3, 6, and 12 months after. The main outcome variable will be re-attempting suicide during follow-up.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Some psychotherapeutic interventions, usually implemented in outpatient, have proven to be effective in preventing suicidal behaviours. The combination of some of these may be a powerful treatment for preventing future SA in patients hospitalised after an MSSA, which is the most severely suicidal subgroup. Moreover, assessment of the biological, clinical and psychometric impact of this new intervention on patients during the first year after the attempt may help understand some of the multi-level factors associated with the effectiveness of psychotherapeutic interventions in MSSAs. The prevalence of high suicide rates requires the design of effective psychological interventions for their prevention, and also in order to design new pharmacological and psychological treatments.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov ID: NCT06238414. Date of registration: 1st February 2024, final update is protocol version 3.0, 19th March 2024.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beneria</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Mental Health, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Catalonia, Spain. anna.beneria@vallhebron.cat.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mental Health and Addictions Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain. anna.beneria@vallhebron.cat.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Catalonia, Spain. anna.beneria@vallhebron.cat.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain. anna.beneria@vallhebron.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motger-Albertí</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mental Health and Addictions Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain. anna.motger.ext@vhir.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Addictive Behaviors Unit, Psychiatry Department, Institute of Neurosciences, IDIBAPS. RIAPAD (Red de investigación de atención primaria en adicciones), Hospital Clínic, Health and Addictions Research Group, Barcelona, Spain. anna.motger.ext@vhir.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quesada-Franco</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Mental Health, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mental Health and Addictions Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arteaga-Henríquez</LastName><ForeName>Gara</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Mental Health, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mental Health and Addictions Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santesteban-Echarri</LastName><ForeName>Olga</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Mood Disorders Program, Foothills Medical Center, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibáñez</LastName><ForeName>Pol</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Mental Health and Addictions Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parramon-Puig</LastName><ForeName>Gemma</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Mental Health, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mental Health and Addictions Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanz-Correcher</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Psychiatry and Mental Health Department, October 12th University Hospital, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Spanish Society of Therapy Based on Mentalization, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galynker</LastName><ForeName>Igor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Carl Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramos-Quiroga</LastName><ForeName>Josep Antoni</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Mental Health, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mental Health and Addictions Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pintor</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consultation-Liaison Psychiatry Unit, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruguera</LastName><ForeName>Pol</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Addictive Behaviors Unit, Psychiatry Department, Institute of Neurosciences, IDIBAPS. RIAPAD (Red de investigación de atención primaria en adicciones), Hospital Clínic, Health and Addictions Research Group, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braquehais</LastName><ForeName>María Dolores</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Mental Health and Addictions Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Universitat Internacional de Catalunya, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT06238414</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Psychiatry</MedlineTA><NlmUniqueID>100968559</NlmUniqueID><ISSNLinking>1471-244X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013406" MajorTopicYN="Y">Suicide, Attempted</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011613" MajorTopicYN="Y">Psychotherapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077252" MajorTopicYN="N">Dialectical Behavior Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083626" MajorTopicYN="N">Psychosocial Intervention</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076563" MajorTopicYN="N">Mentalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Intervention</Keyword><Keyword MajorTopicYN="N">Medically Serious Suicide Attempts (MSSA)</Keyword><Keyword MajorTopicYN="N">Psychotherapeutic intervention</Keyword><Keyword MajorTopicYN="N">Psychotherapy</Keyword><Keyword MajorTopicYN="N">Randomised controlled trial</Keyword><Keyword MajorTopicYN="N">Suicide attempt</Keyword></KeywordList><CoiStatement>J.A.R.Q was on the speakers’ bureau and/or has acted as a consultant for Biogen, Idorsia, Janssen-Cilag, Novartis, Takeda, Bial, Sincrolab, Neuraxpharm, Novartis, BMS, Medice, Rubió, Uriach, Technofarma and Raffo in the last 3 years. He also received travel grants (air tickets + hotel) to attend psychiatric meetings held by Idorsia, Janssen-Cilag, Rubió, Takeda, Bial and Medice. The Department of Psychiatry that he chairs has received unrestricted educational and research support from the following companies in the last 3 years: Exeltis, Idorsia, Janssen- Cilag, Neuraxpharm, Oryzon, Roche, Probitas, Psious, and Rubió.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>7</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>23</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39379877</ArticleId><ArticleId IdType="pmc">PMC11462794</ArticleId><ArticleId IdType="doi">10.1186/s12888-024-06113-3</ArticleId><ArticleId IdType="pii">10.1186/s12888-024-06113-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. Suicide worldwide in 2019: Global Health Estimates [Internet]. World Health Organization,Geneva. 2019. 4–9 p. https://apps.who.int/iris/rest/bitstreams/1350975/retrieve</Citation></Reference><Reference><Citation>Cerel J, Jordan JR, Duberstein PR. The impact of suicide on the family. Crisis. 2008;29(1):38–44.</Citation><ArticleIdList><ArticleId IdType="pubmed">18389644</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitman A, Osborn D, King M, Erlangsen A. Effects of suicide bereavement on mental health and suicide risk. Lancet Psychiatry. 2014;1(1):86–94.</Citation><ArticleIdList><ArticleId IdType="pubmed">26360405</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu C, Buchman-Schmitt JM, Stanley IH, Hom MA, Tucker RP, Hagan CR, et al. The interpersonal theory of suicide: a systematic review and meta-analysis of a decade of cross-national research. Psychol Bull. 2017;143(12):1313–45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5730496</ArticleId><ArticleId IdType="pubmed">29072480</ArticleId></ArticleIdList></Reference><Reference><Citation>INE. Defunciones según la Causa De Muerte. Notas De Prensa. 2021;2021:19.</Citation></Reference><Reference><Citation>Intituto Nacional de Estadística. Defunciones según la causa de muerte - año 2022 (datos provisionales). 2023;2022:1–6. https://www.ine.es/ss/Satellite?L=0&amp;c=INECifrasINE_C&amp;cid=1259954008107&amp;p=1254735116567&amp;pagename=Pr</Citation></Reference><Reference><Citation>Beneria A, Marte L, Quesada-Franco M, García-González S, Restoy D, Pérez-Galbarro C, et al. Trends in medically serious suicide attempts before and after the COVID-19: a four-year retrospective analysis [Preprint]. 2018–2022 [cited 2023 July 19] (Version 1). Available from: 10.21203/rs.3.rs-3093002/v1</Citation></Reference><Reference><Citation>Kawohl W, Nordt C. COVID-19, unemployment, and suicide. The lancet. Volume 7. Psychiatry. England; 2020. pp. 389–90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185950</ArticleId><ArticleId IdType="pubmed">32353269</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers SL, Cruickshank T. Change in mental health, physical health, and social relationships during highly restrictive lockdown in the COVID-19 pandemic: evidence from Australia. PeerJ. 2021;9:e11767.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8310621</ArticleId><ArticleId IdType="pubmed">34327055</ArticleId></ArticleIdList></Reference><Reference><Citation>Beautrais AL. Further suicidal behavior among medically serious suicide attempters. Suicide Life Threat Behav. 2004;34(1):1–11.</Citation><ArticleIdList><ArticleId IdType="pubmed">15106883</ArticleId></ArticleIdList></Reference><Reference><Citation>Beautrais AL, Joyce PR, Mulder RT. Risk factors for serious suicide attempts among youths aged 13 through 24 years. J Am Acad Child Adolesc Psychiatry. 1996;35(9):1174–82.</Citation><ArticleIdList><ArticleId IdType="pubmed">8824061</ArticleId></ArticleIdList></Reference><Reference><Citation>Beautrais AL. Suicides and serious suicide attempts: two populations or one? Psychol Med. 2001;31(5):837–45.</Citation><ArticleIdList><ArticleId IdType="pubmed">11459381</ArticleId></ArticleIdList></Reference><Reference><Citation>Beautrais AL. Suicide and serious suicide attempts in youth: a multiple-group comparison study. Am J Psychiatry. 2003;160(6):1093–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12777267</ArticleId></ArticleIdList></Reference><Reference><Citation>Quesada-Franco M, Pintor-Pérez L, Daigre C, Baca-García E, Ramos-Quiroga JA, Braquehais MD. Medically serious suicide attempts in Personality disorders. J Clin Med. 2021;10:18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8469317</ArticleId><ArticleId IdType="pubmed">34575302</ArticleId></ArticleIdList></Reference><Reference><Citation>Luoma JB, Martin CE, Pearson JL. Contact with mental health and primary care providers before suicide: a review of the evidence. Am J Psychiatry. 2002;159(6):909–16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5072576</ArticleId><ArticleId IdType="pubmed">12042175</ArticleId></ArticleIdList></Reference><Reference><Citation>Owens C, Booth N, Briscoe M, Lawrence C, Lloyd K. Suicide outside the care of mental health services: a case-controlled psychological autopsy study. Crisis. 2003;24(3):113–21.</Citation><ArticleIdList><ArticleId IdType="pubmed">14518644</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamdi E, Price S, Qassem T, Amin Y, Jones D. Suicides not in contact with mental health services: Risk indicators and determinants of referral. J Ment Heal [Internet]. 2008;17(4):398–409. 10.1080/09638230701506234</Citation></Reference><Reference><Citation>Cleary A. Suicidal action, emotional expression, and the performance of masculinities. Soc Sci Med. 2012;74(4):498–505.</Citation><ArticleIdList><ArticleId IdType="pubmed">21930333</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Brien R, Hunt K, Hart G. ‘It’s caveman stuff, but that is to a certain extent how guys still operate’: men’s accounts of masculinity and help seeking. Soc Sci Med [Internet]. 2005;61(3):503–16. https://www.sciencedirect.com/science/article/pii/S0277953605000031</Citation><ArticleIdList><ArticleId IdType="pubmed">15899311</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Orden KA, Witte TK, Cukrowicz KC, Braithwaite SR, Selby EA, Joiner TEJ. The interpersonal theory of suicide. Psychol Rev. 2010;117(2):575–600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3130348</ArticleId><ArticleId IdType="pubmed">20438238</ArticleId></ArticleIdList></Reference><Reference><Citation>Joiner TEJ, Brown JS, Wingate LR. The psychology and neurobiology of suicidal behavior. Annu Rev Psychol. 2005;56:287–314.</Citation><ArticleIdList><ArticleId IdType="pubmed">15709937</ArticleId></ArticleIdList></Reference><Reference><Citation>Galynker I, Yaseen ZS, Cohen A, Benhamou O, Hawes M, Briggs J. Prediction of suicidal behavior in high risk psychiatric patients using an assessment of acute suicidal state: the suicide crisis inventory. Depress Anxiety. 2017;34(2):147–58.</Citation><ArticleIdList><ArticleId IdType="pubmed">27712028</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen L, Mokhtar R, Richards J, Hernandez M, Bloch-Elkouby S, Galynker I. The Narrative-Crisis Model of suicide and its prediction of near‐term suicide risk. Suicide Life-Threatening Behav. 2021;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">34766360</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert P, Gilbert J. Entrapment and arrested fight and flight in depression: an exploration using focus groups. Psychol Psychother. 2003;76(Pt 2):173–88.</Citation><ArticleIdList><ArticleId IdType="pubmed">12855063</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Galynker II, Briggs J, Duffy M, Frechette-Hagan A, Kim HJ, et al. Attachment style and suicide behaviors in high risk psychiatric inpatients following hospital discharge: the mediating role of entrapment. Psychiatry Res. 2017;257:309–14.</Citation><ArticleIdList><ArticleId IdType="pubmed">28797954</ArticleId></ArticleIdList></Reference><Reference><Citation>Capuzzi E, Caldiroli A, Capellazzi M, Tagliabue I, Buoli M, Clerici M. Biomarkers of suicidal behaviors: a comprehensive critical review. Adv Clin Chem. 2020;96:179–216.</Citation><ArticleIdList><ArticleId IdType="pubmed">32362318</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci [Internet]. 2003;4(10):819–28. 10.1038/nrn1220</Citation><ArticleIdList><ArticleId IdType="pubmed">14523381</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann JJ. The serotonergic system in mood disorders and suicidal behaviour. Philos Trans R Soc Lond Ser B Biol Sci. 2013;368(1615):20120537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3638390</ArticleId><ArticleId IdType="pubmed">23440471</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulougouris V, Malogiannis I, Lockwood G, Zervas I, Di Giovanni G. Serotonergic modulation of suicidal behaviour: integrating preclinical data with clinical practice and psychotherapy. Exp Brain Res. 2013;230(4):605–24.</Citation><ArticleIdList><ArticleId IdType="pubmed">23975151</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernández-Sevillano J, González-Pinto A, Rodríguez-Revuelta J, Alberich S, Gónzalez-Blanco L, Zorrilla I, et al. Suicidal behaviour and cognition: a systematic review with special focus on prefrontal deficits. J Affect Disord. 2021;278:488–96.</Citation><ArticleIdList><ArticleId IdType="pubmed">33017675</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernández-Sevillano J, Alberich S, Zorrilla I, González-Ortega I, López MP, Pérez V, et al. Cognition in recent suicide attempts: altered executive function. Front Psychiatry. 2021;12:701140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339467</ArticleId><ArticleId IdType="pubmed">34366931</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernández-Sevillano J, González-Ortega I, MacDowell K, Zorrilla I, López MP, Courtet P, et al. Inflammation biomarkers in suicide attempts and their relation to abuse, global functioning and cognition. World J Biol Psychiatry off J World Fed Soc Biol Psychiatry. 2022;23(4):307–17.</Citation><ArticleIdList><ArticleId IdType="pubmed">34730074</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiweck C, Valles-Colomer M, Arolt V, Müller N, Raes J, Wijkhuijs A, et al. Depression and suicidality: a link to premature T helper cell aging and increased Th17 cells. Brain Behav Immun. 2020;87:603–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32061905</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindqvist D, Janelidze S, Erhardt S, Träskman-Bendz L, Engström G, Brundin L. CSF biomarkers in suicide attempters–a principal component analysis. Acta Psychiatr Scand. 2011;124(1):52–61.</Citation><ArticleIdList><ArticleId IdType="pubmed">21198458</ArticleId></ArticleIdList></Reference><Reference><Citation>Sublette ME, Galfalvy HC, Fuchs D, Lapidus M, Grunebaum MF, Oquendo MA, et al. Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder. Brain Behav Immun. 2011;25(6):1272–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3468945</ArticleId><ArticleId IdType="pubmed">21605657</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryleva EY, Brundin L. Kynurenine pathway metabolites and suicidality. Neuropharmacology. 2017;112(Pt B):324–30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5998805</ArticleId><ArticleId IdType="pubmed">26820800</ArticleId></ArticleIdList></Reference><Reference><Citation>Linehan MM, Korslund KE, Harned MS, Gallop RJ, Lungu A, Neacsiu AD, et al. Dialectical behavior therapy for high suicide risk in individuals with borderline personality disorder: a randomized clinical trial and component analysis. JAMA Psychiatry. 2015;72(5):475–82.</Citation><ArticleIdList><ArticleId IdType="pubmed">25806661</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Liu D, Wang Y, Chen Y, Chen W, Yang C, et al. Effectiveness of Zhong-Yong thinking based dialectical behavior therapy group skills training versus supportive group therapy for lowering suicidal risks in Chinese young adults: a randomized controlled trial with a 6-month follow-up. Brain Behav. 2020;10(6):e01621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7303376</ArticleId><ArticleId IdType="pubmed">32304353</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryan CJ, Rozek DC. Suicide prevention in the military: a mechanistic perspective. Curr Opin Psychol. 2018;22:27–32.</Citation><ArticleIdList><ArticleId IdType="pubmed">30122274</ArticleId></ArticleIdList></Reference><Reference><Citation>Conner KR, Kearns JC, Esposito EC, Pizzarello E, Wiegand TJ, Britton PC, et al. Pilot RCT of the Attempted Suicide Short Intervention Program (ASSIP) adapted for rapid delivery during hospitalization to adult suicide attempt patients with substance use problems. Gen Hosp Psychiatry. 2021;72:66–72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8448954</ArticleId><ArticleId IdType="pubmed">34304029</ArticleId></ArticleIdList></Reference><Reference><Citation>Gysin-Maillart A, Schwab S, Soravia L, Megert M, Michel K. A novel brief therapy for patients who attempt suicide: a 24-months Follow-Up Randomized Controlled Study of the Attempted Suicide Short Intervention Program (ASSIP). PLoS Med. 2016;13(3):e1001968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4773217</ArticleId><ArticleId IdType="pubmed">26930055</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossouw TI, Fonagy P. Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry. 2012;51(12):1304–e13133.</Citation><ArticleIdList><ArticleId IdType="pubmed">23200287</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths H, Duffy F, Duffy L, Brown S, Hockaday H, Eliasson E, et al. Efficacy of Mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry. 2019;19(1):167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6554935</ArticleId><ArticleId IdType="pubmed">31170947</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman A, Fonagy P. Mentalization based treatment for borderline personality disorder. World Psychiatry. 2010;9(1):11–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2816926</ArticleId><ArticleId IdType="pubmed">20148147</ArticleId></ArticleIdList></Reference><Reference><Citation>Riblet NB, Shiner B, Schnurr P, Bruce ML, Wasserman D, Cornelius S, et al. A pilot study of an intervention to prevent suicide after Psychiatric hospitalization. J Nerv Ment Dis. 2019;207(12):1031–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8801296</ArticleId><ArticleId IdType="pubmed">31688286</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan A-W, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin J, Dickersin K, Hróbjartsson A, Schulz KF, Parulekar WR, Krleža-Jerić K, Laupacis A, Moher D. SPIRIT 2013 explanation and elaboration: Guidance for protocols of clinical trials. BMJ. 2013;346:e7586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3541470</ArticleId><ArticleId IdType="pubmed">23303884</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inf. 2019;95:103208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox DR. Regression models and life-tables. J R Stat Soc Ser B. 1972;34(2):187–202.</Citation></Reference><Reference><Citation>American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, text revision. Washington, DC: American Psychiatric Association; 2022.</Citation></Reference><Reference><Citation>Bateman A, Fonagy P. Grupo introducción a la MBT (MBT-I). In: Bateman A, Fonagy P, editors. Tratamiento basado en la mentalización para Los trastornos de personalidad. Una guía práctica. 2nd ed. UK. Desclée de Brower; 2016. pp. 417–87.</Citation></Reference><Reference><Citation>Bateman A, Fonagy P. Mentalization-Based Treatment for Personality Disorders: A Practical Guide [Internet]. Oxford University Press; 2016. 10.1093/med:psych/9780199680375.001.0001</Citation></Reference><Reference><Citation>Linehan M. Skills Training Manual for Treating Borderline Personality Disorder, First Ed [Internet]. Guilford Publications; 1993. (Diagnosis and Treatment of Mental Disorders). https://books.google.es/books?id=iCM6BAAAQBAJ</Citation></Reference><Reference><Citation>Mentalizing and Emergency Care. In pp. 364–87. https://www.cambridge.org/core/product/6B976C284C38BCD60B7A026A9398ED59</Citation></Reference><Reference><Citation>Karsen E, Cohen LJ, White B, De GP, Goncearencoa I, Galynker II et al. Impact of the abbreviated suicide Crisis Syndrome Checklist on clinical decision making in the Emergency Department. J Clin Psychiatry. 2023;84(3).</Citation><ArticleIdList><ArticleId IdType="pubmed">37134117</ArticleId></ArticleIdList></Reference><Reference><Citation>Kar N, Arun M, Mohanty MK, Bastia BK. Scale for assessment of lethality of suicide attempt. Indian J Psychiatry. 2014;56(4):337–43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4279290</ArticleId><ArticleId IdType="pubmed">25568473</ArticleId></ArticleIdList></Reference><Reference><Citation>Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, et al. The Columbia-suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168(12):1266–77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3893686</ArticleId><ArticleId IdType="pubmed">22193671</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck RW, Morris JB, Beck AT. Cross-validation of the suicidal intent scale. Psychol Rep. 1974;34(2):445–6.</Citation><ArticleIdList><ArticleId IdType="pubmed">4820501</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck AT, Steer RA, Ranieri WF. Scale for suicide ideation: psychometric properties of a self-report version. J Clin Psychol. 1988;44(4):499–505.</Citation><ArticleIdList><ArticleId IdType="pubmed">3170753</ArticleId></ArticleIdList></Reference><Reference><Citation>Burckhardt CS, Anderson KL, Archenholtz B, Hägg O. The flanagan quality of life scale: evidence of construct validity. Health Qual Life Outcomes. 2003;1(59):1–7. 10.1186/1477-7525-1-59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC269996</ArticleId><ArticleId IdType="pubmed">14613563</ArticleId></ArticleIdList></Reference><Reference><Citation>Shneidman ES. The psychological pain assessment scale. Suicide Life Threat Behav. 1999;29(4):287–94.</Citation><ArticleIdList><ArticleId IdType="pubmed">10636323</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.</Citation><ArticleIdList><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol. 1974;42(6):861–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">4436473</ArticleId></ArticleIdList></Reference><Reference><Citation>Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol. 1995;51(6):768–74.</Citation><ArticleIdList><ArticleId IdType="pubmed">8778124</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Parra E, Manzano-García G, Mediavilla R, Rodríguez-Vega B, Lahera G, Moreno-Pérez AI, et al. The Spanish version of the reflective functioning questionnaire: validity data in the general population and individuals with personality disorders. PLoS ONE. 2023;18(4):e0274378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10079014</ArticleId><ArticleId IdType="pubmed">37023214</ArticleId></ArticleIdList></Reference><Reference><Citation>Balluerka N, Lacasa F, Gorostiaga A, Muela A, Pierrehumbert B. Versión reducida del cuestionario CaMir (CaMir-R) para la evaluación del apego. Psicothema. 2011;23(3):486–94.</Citation><ArticleIdList><ArticleId IdType="pubmed">21774904</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>